IP Library Patent Application 12520814
Patent Application
App. No. 12/520,814

COATED MEDICAL DEVICES WITH ADHESION PROMOTERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/520,814
Abstract

A medical device includes a polymer composition on a surface. The polymer composition is bonded to a surface of the medical device using an adhesion promoter.

Claims (34)

1 . A process for producing a medical device, comprising:

applying an adhesion promoting composition to a portion of a surface of a medical device, wherein the surface of the device comprises a plurality of surface functional groups, and the adhesion promoting composition comprises an adhesion promoter, the adhesion promoter including a promoter functional group capable of reacting with the surface functional groups, the adhesion promoting composition being applied under conditions selected to cause reaction between the promoter functional groups and the surface functional groups, and wherein the adhesion promoter retains a plurality of unreacted promoter functional groups after reaction with the surface functional groups;

applying a polymer composition to a portion of the surface of the device, the polymer composition comprising a plurality of polymer functional groups capable of reacting with promoter functional groups, the polymer composition being applied under conditions selected to cause reaction between the promoter functional groups and the polymer functional groups; and

applying a biopolymer composition to a portion of the surface of the device, wherein the biopolymer composition comprises a therapeutic or diagnostic agent.

2 . The process of claim 1 , wherein reaction between the promoter functional groups and the surface functional groups forms a plurality of covalent bonds between the adhesion promoter and the surface of the device.

3 . The process of claim 1 , wherein reaction between the promoter functional groups and the polymer functional groups forms a plurality of covalent bonds between the adhesion promoter and the polymer composition.

4 . The process of claim 1 , further comprising treating the surface of the device with an ionizing treatment.

5 . (canceled)

6 . The process of claim 1 , wherein the device includes a polymer substrate.

7 . The process of claim 6 , wherein the polymer substrate is a silicone, a polyimide, a PTFE, a polyethylene, or a polyester.

8 . The process of claim 1 , wherein the device includes a metal substrate.

9 . The process of claim 8 , wherein the metal substrate is titanium, stainless steel, nickel, gold, chrome, tantalum, nitinol, platinum, silver, cobalt, an alloy including titanium, an alloy including stainless steel, an alloy including nickel, an alloy including gold, an alloy including chrome, an alloy including tantalum, an alloy including platinum, an alloy including silver, or an alloy including cobalt.

10 . The process of claim 1 , wherein the adhesion promoter includes an organic titanate.

11 - 12 . (canceled)

13 . The process of claim 1 , wherein the biopolymer composition includes a lubricious component.

14 - 19 . (canceled)

20 . A process for producing a medical device, comprising:

applying an adhesion promoting composition to a portion of a surface of a medical device, wherein the surface of the device comprises a plurality of surface functional groups, and the adhesion promoting composition comprises an adhesion promoter, the adhesion promoter including a promoter functional group capable of reacting with the surface functional groups, the adhesion promoting composition being applied under conditions selected to cause reaction between the promoter functional groups and the surface functional groups, and wherein the adhesion promoter retains a plurality of unreacted promoter functional groups after reaction with the surface functional groups; and

applying a biopolymer composition to a portion of the surface of the device, wherein the biopolymer composition comprises a therapeutic or diagnostic agent.

21 . The process of claim 20 , wherein reaction between the promoter functional groups and the surface functional groups forms a plurality of covalent bonds between the adhesion promoter and the surface of the device.

22 . The process of claim 20 , wherein reaction between the promoter functional groups and the polymer functional groups forms a plurality of covalent bonds between the adhesion promoter and the biopolymer composition.

23 . The process of claim 20 , further comprising treating the surface of the device with an ionizing treatment.

24 - 26 . (canceled)

27 . The process of claim 20 , wherein the device includes a metal substrate.

28 . The process of claim 27 , wherein the metal substrate is titanium, stainless steel, nickel, gold, chrome, tantalum, nitinol, platinum, silver, cobalt, an alloy including titanium, an alloy including stainless steel, an alloy including nickel, an alloy including gold, an alloy including chrome, an alloy including tantalum, an alloy including platinum, an alloy including silver, or an alloy including cobalt.

29 . The process of claim 20 , wherein the adhesion promoter includes an organic titanate.

30 - 31 . (canceled)

32 . The process of claim 20 , wherein the biopolymer composition includes a lubricious component.

33 - 39 . (canceled)

40 . A medical device comprising a coating on a portion of a surface the device, wherein the coating comprises a polymer composition and a linking group forming a covalent bond between the surface of the device and a component of the polymer composition, wherein the covalent bond includes a metal ether linkage.

41 . The medical device of claim 40 , wherein the metal ether linkage is a titanium ether linkage.

42 - 43 . (canceled)

44 . The medical device of claim 40 , wherein the polymer composition includes a biopolymer composition.

45 - 52 . (canceled)

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded May 7, 2019
From: VIRTUS GROUP, LP, AS ADMINISTRATIVE AGENT FOR THE LENDERS
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 049106/0137 →
SECURITY INTEREST Recorded Mar 10, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: VIRTUS GROUP, LP
Reel/Frame 041539/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2014
From: ANGIOTECH BIOCOATINGS CORP.
To: ANGIOTECH PHARMACEUTICALS (US), INC.
Reel/Frame 034034/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2013
From: ANGIOTECH PHARMACEUTICALS (US), INC.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 031510/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 15, 2013
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030218/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2013
From: ANGIOTECH BIOCOATINGS CORP.
To: ANGIOTECH PHARMACEUTICALS (US), INC.
Reel/Frame 029930/0255 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2010
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDIA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALITIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 024861/0219 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2010
From: OLTEAN, GEORGE LESLIE; CALISTRI-YEH, MILDRED; COPENHAGEN, DONALD MICHAEL
To: ANGIOTECH BIOCOATINGS CORP.
Reel/Frame 024462/0591 →
SECURITY AGREEMENT Recorded Aug 31, 2009
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 023172/0394 →